Doggybone DNA vaccine provides long lasting immunity against SARS CoV 2 than Covaxin

Durable and balanced immune responses are critical for effectual SARS-CoV-2 vaccination. We compared the immunogenicity of a novel linear doggybone DNA vaccine encoding the full length membrane anchored spike protein of SARS-CoV-2 spike protein (S-dbDNA) with that of a licensed inactivated whole-virion vaccine, Covaxin, in a murine model. S-dbDNA induced significantly higher anti-S1 IgG titres with strong reactivity to the RBD (receptor-binding domain) and superior neutralization of virulent SARS-CoV-2. S-dbDNA also elicited higher frequencies of mono- and polyfunctional CD4 + and CD8 + T cells, along with cytokine-producing NK and NKT cells, compared with Covaxin. Importantly, S-dbDNA generated more durable immune memory, with sustained antibody, neutralization, and T-cell responses detectable up to 120 days post-immunization. These findings support linear DNA vaccines as a promising platform for SARS-CoV-2 and emerging pathogens.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-14
DOI
https://doi.org/10.1038/s41598-026-76912-z
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Doggybone DNA vaccine provides long lasting immunity against SARS CoV 2 than Covaxin

Moumita Bhaumik, Sharad Singh, Koustav Chatterjee, Ankita Dutta et al.
1 links
Scientific Reports
SARS-CoV-2 and COVID-19 Research
article

Doggybone DNA vaccine provides long lasting immunity against SARS CoV 2 than Covaxin

Moumita Bhaumik, Sharad Singh, Koustav Chatterjee, Ankita Dutta, Soma Chattopadhyay, Lisa J. Caproni, Rajshree Rajmohan Jena, Aaheli Masid, Shantanabha Das
article en

Abstract

Durable and balanced immune responses are critical for effectual SARS-CoV-2 vaccination. We compared the immunogenicity of a novel linear doggybone DNA vaccine encoding the full length membrane anchored spike protein of SARS-CoV-2 spike protein (S-dbDNA) with that of a licensed inactivated whole-virion vaccine, Covaxin, in a murine model. S-dbDNA induced significantly higher anti-S1 IgG titres with strong reactivity to the RBD (receptor-binding domain) and superior neutralization of virulent SARS-CoV-2. S-dbDNA also elicited higher frequencies of mono- and polyfunctional CD4 + and CD8 + T cells, along with cytokine-producing NK and NKT cells, compared with Covaxin. Importantly, S-dbDNA generated more durable immune memory, with sustained antibody, neutralization, and T-cell responses detectable up to 120 days post-immunization. These findings support linear DNA vaccines as a promising platform for SARS-CoV-2 and emerging pathogens.

Scientific Reports
Manipal Academy of Higher Education (IN), Diamond Harbour Women's University (IN), Indian Council of Medical Research (IN), National Institute of Cholera and Enteric Diseases (IN), Institute of Life Sciences (IN), KIIT University (IN)
Indian Council of Medical Research
Good health and well-being
SARS-CoV-2 and COVID-19 Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon